Difference between revisions of "Espinoza I, et al. Pharmacol. Ther. (2013) cited as Ref 191 in DOI: 10.1038/s41392-020-0110-5 (Q9454)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 139, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: Page(s) (P105): 95-110, #quickstatements; #temporary_batch_1590074839150) |
||
| (One intermediate revision by the same user not shown) | |||
| Property / title | |||
| + | Notch inhibitors for cancer treatment (English) | ||
| Property / title: Notch inhibitors for cancer treatment (English) / rank | |||
| + | Normal rank | ||
| Property / Page(s) | |||
| + | 95-110 | ||
| Property / Page(s): 95-110 / rank | |||
| + | Normal rank | ||
Latest revision as of 15:33, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Espinoza I, et al. Pharmacol. Ther. (2013) cited as Ref 191 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Espinoza I
0 references
Miele L
0 references
2013
0 references
Pharmacol. Ther.
0 references
139
0 references
Notch inhibitors for cancer treatment (English)
0 references
95-110
0 references
